35 results on '"Monie, Dileep"'
Search Results
2. Hybrid tumors with perineurioma components: a systematic review of the literature and illustrative case
3. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
4. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
5. Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas
6. Oncolytic virus-derived type I interferon restricts CAR T cell therapy
7. Bioprinting of Dynamic Human Organs-on-Chips: Enabling Technologies for Rapid Drug Development and Personalized Medicine
8. Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
9. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
10. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
11. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma
12. Hybrid tumors with perineurioma components: a systematic review of the literature and illustrative case
13. 53123 Role of Cellular Senescence in Human Diabetic Foot Ulcers
14. Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases
15. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I–associated neurologic disease
16. NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
17. Bioprinting of Dynamic Human Organs-on-Chips: Enabling Technologies for Rapid Drug Development and Personalized Medicine
18. Abstract 1679: Innate immunity and cytokine signaling pathways drive resistance to HSV-1 oncolytic immunovirotherapy in glioblastoma
19. Emerging workforce readiness in regenerative healthcare
20. Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma
21. NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
22. Ependymal Petechial Hemorrhages in Bacterial Meningitis
23. Network-guided bioengineering of oncolytic immunovirotherapies for glioblastoma
24. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature
25. NIMG-39. REVEALING THE TUMOR-IMMUNE LANDSCAPE THROUGH SPATIALLY-RESOLVED RADIOMICS: CASE STUDIES
26. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity
27. Measuring the activity of BioBrick promoters using an in vivo reference standard
28. Pathogenesis of thrombosis: cellular and pharmacogenetic contributions
29. Measuring the activity of BioBrick promoters using an in vivo reference standard
30. Measuring the activity of BioBrick promoters using an in vivo reference standard
31. NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
32. Abstract 3561: The radiosensitizing and cytotoxic effects of PBS-1086, a Rel inhibitor of NF-KB, in breast cancer cells
33. Unique Superantigen Activity of Staphylococcal Exfoliative Toxins
34. NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
35. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.